Outcomes and predictors of very stable INR control during chronic anticoagulation therapy
Open Access
- 30 July 2009
- journal article
- Published by American Society of Hematology in Blood
- Vol. 114 (5), 952-956
- https://doi.org/10.1182/blood-2009-02-207928
Abstract
For patients on warfarin therapy, an international normalized ratio (INR) recall interval not exceeding 4 weeks has traditionally been recommended. Less frequent INR monitoring may be feasible in stable patients. We sought to identify patients with stable INRs (defined as having INR values exclusively within the INR range) and comparator patients (defined as at least one INR outside the INR range) in a retrospective, longitudinal cohort study. Occurrences of thromboembolism, bleeding, and death were compared between groups. Multivariate logistic regression models were used to identify independent predictors of stable INR control. There were 2504 stable and 3569 comparator patients. The combined rates of bleeding and thromboembolism were significantly lower in stable patients. Independent predictors of stable INR control were age older than 70 years and the absence of comorbid heart failure and diabetes. Stable patients were significantly less likely to have target INR of 3.0 or higher or chronic diseases. We hypothesize that many patients demonstrating stable INR control could be safely treated with INR recall intervals greater than the traditional 4 weeks.Keywords
This publication has 21 references indexed in Scilit:
- Warfarin dose management affects INR controlJournal of Thrombosis and Haemostasis, 2008
- Oral anticoagulation should be managed in the community with treatment aimed at standard therapeutic targets and increased recall intervalsJournal of Thrombosis and Haemostasis, 2008
- Warfarin for atrial fibrillation in community‐based practiseJournal of Thrombosis and Haemostasis, 2008
- Pharmacology and Management of the Vitamin K Antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)Social psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2008
- Influence of CYP2C9 and VKORC1 on Warfarin Dose, Anticoagulation Attainment and Maintenance Among European–Americans and African–AmericansPharmacogenomics, 2008
- ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm SocietyEP Europace, 2006
- ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial FibrillationCirculation, 2006
- Patients with unstable control have a poorer dietary intake of vitamin K compared to patients with stable control of anticoagulationThrombosis and Haemostasis, 2005
- Guidelines on oral anticoagulation: third editionBritish Journal of Haematology, 1998
- A chronic disease score from automated pharmacy dataJournal of Clinical Epidemiology, 1992